Zhou, Lingyun http://orcid.org/0000-0002-6756-6725
He, Linye
Liu, Chang-Hai
Qiu, Huandi
Zheng, Li
Sample, Klarke Michael
Wu, Qin
Li, Jiaxin
Xie, Kunlin
Ampuero, Javier
Li, Zhihui
Lv, Duoduo
Liu, Miao
Romero-Gómez, Manuel
Hu, Yiguo
Tang, Hong
Funding for this research was provided by:
National Natural Science Foundation of China (81802468, 82172254, 82170114, 81770103, 82002572)
West China Hospital, Sichuan University (ZYGD20009, Z20201008, ZYJC18025)
Sichuan Province Science and Technology Support Program (2023YFS0088, 2022YFS0338, 2022JDRC0135, 2021YFH0095)
Sichuan University (2022SCUH0017)
Article History
Received: 10 August 2023
Accepted: 10 November 2023
First Online: 22 November 2023
Declarations
:
: All the clinical samples were collected after obtaining informed consent and used in accordance with the Declaration of Helsinki and the guidelines of the Ethical Committee of the West China Hospital (No. 2016–91, No. 2019–905). All animal studies were performed per the guidelines and with approval from the Sichuan University Institutional Animal Care and Use Committee (No. 20220228071).
: All the authors have read, approved the manuscript, and agreed to its submission to the Journal of Experimental and Clinical Cancer Research<i>.</i>
: The authors declare no competing interests.